Atlas Trials

Minimal Effective Concentration (EC90) of Ropivacaine

Clinical trial NCT03688269 · COMPLETED

Trial details

NCT number
NCT03688269
Sponsor
Centre Hospitalier Universitaire de Besancon
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Anesthesia, ConductionRopivacaineDexamethasoneAxillary Brachial Plexus Block
Start date
2018-10-05
Primary completion
2019-11-04
Enrollment
146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.